127 related articles for article (PubMed ID: 19917059)
1. Novel human papillomavirus type 18 replicon and its application in screening the antiviral effects of cytokines.
Satsuka A; Yoshida S; Kajitani N; Nakamura H; Sakai H
Cancer Sci; 2010 Feb; 101(2):536-42. PubMed ID: 19917059
[TBL] [Abstract][Full Text] [Related]
2. NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.
Banerjee NS; Moore DW; Wang HK; Broker TR; Chow LT
Antiviral Res; 2019 Oct; 170():104559. PubMed ID: 31319090
[No Abstract] [Full Text] [Related]
3. Targeting DNA Damage Response as a Strategy to Treat HPV Infections.
Banerjee NS; Moore D; Parker CJ; Broker TR; Chow LT
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683862
[TBL] [Abstract][Full Text] [Related]
4. Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.
Luo Y; Yu F; Zhou M; Liu Y; Xia B; Zhang X; Liu J; Zhang J; Du Y; Li R; Wu L; Zhang X; Pan T; Guo D; Peng T; Zhang H
mBio; 2021 Jan; 12(1):. PubMed ID: 33468688
[TBL] [Abstract][Full Text] [Related]
5. Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay.
Toots M; Ustav M; Männik A; Mumm K; Tämm K; Tamm T; Ustav E; Ustav M
PLoS Pathog; 2017 Feb; 13(2):e1006168. PubMed ID: 28182794
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Human Papillomavirus 18 Genome Replication, Establishment, and Persistence by Sequences in the Viral Upstream Regulatory Region.
Coursey TL; Van Doorslaer K; McBride AA
J Virol; 2021 Sep; 95(19):e0068621. PubMed ID: 34232709
[TBL] [Abstract][Full Text] [Related]
7. Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.
Banerjee NS; Moore DW; Broker TR; Chow LT
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11138-E11147. PubMed ID: 30385631
[TBL] [Abstract][Full Text] [Related]
8. HPV episome levels are potently decreased by pyrrole-imidazole polyamides.
Edwards TG; Koeller KJ; Slomczynska U; Fok K; Helmus M; Bashkin JK; Fisher C
Antiviral Res; 2011 Aug; 91(2):177-86. PubMed ID: 21669229
[TBL] [Abstract][Full Text] [Related]
9. Development of protein-based antiviral drugs for human papillomaviruses.
Mino T; Mori T; Aoyama Y; Sera T
Nucleic Acids Symp Ser (Oxf); 2007; (51):427-8. PubMed ID: 18029769
[TBL] [Abstract][Full Text] [Related]
10. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.
Lace MJ; Anson JR; Klingelhutz AJ; Lee JH; Bossler AD; Haugen TH; Turek LP
J Virol; 2009 Nov; 83(22):11784-94. PubMed ID: 19740985
[TBL] [Abstract][Full Text] [Related]
12. HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures.
Kho EY; Wang HK; Banerjee NS; Broker TR; Chow LT
Proc Natl Acad Sci U S A; 2013 May; 110(19):7542-9. PubMed ID: 23572574
[TBL] [Abstract][Full Text] [Related]
13. Development of Basal-Like HaCaT Keratinocytes Containing the Genome of Human Papillomavirus (HPV) Type 11 for Screening of Anti-HPV Effects.
Wang Y; Li X; Song S; Wu J
J Biomol Screen; 2014 Sep; 19(8):1154-63. PubMed ID: 24874507
[TBL] [Abstract][Full Text] [Related]
14. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 replicon for high-throughput antiviral screening.
Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ
J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592
[TBL] [Abstract][Full Text] [Related]
16. Novel recombinant papillomavirus genomes expressing selectable genes.
Van Doorslaer K; Porter S; McKinney C; Stepp WH; McBride AA
Sci Rep; 2016 Nov; 6():37782. PubMed ID: 27892937
[TBL] [Abstract][Full Text] [Related]
17. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes.
Thomas JT; Oh ST; Terhune SS; Laimins LA
J Virol; 2001 Aug; 75(16):7564-71. PubMed ID: 11462028
[TBL] [Abstract][Full Text] [Related]
18. Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.
Gu B; Ouzunov S; Wang L; Mason P; Bourne N; Cuconati A; Block TM
Antiviral Res; 2006 Jun; 70(2):39-50. PubMed ID: 16724398
[TBL] [Abstract][Full Text] [Related]
19. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
20. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
Nguyen HT; Falzarano D; Gerdts V; Liu Q
J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
